The circular RNA circSLC7A11 functions as a mir-330-3p sponge to accelerate hepatocellular carcinoma progression by

Yu Huang1,2,3,4,5,6, Wenhao Ge1,2,3,4,5,6, Yuan Ding1,2,3,4,5,6

  • 1Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, No. 88 Jiefang Road, Hangzhou, 310009, Zhejiang, China.

Cancer Cell International
|November 30, 2021
PubMed
Abstract

Insights

Circular RNAs (circRNAs) accelerate hepatocellular carcinoma (HCC) progression and metastasis. CircSLC7A11 promotes HCC via the circSLC7A11/miR-330-3p/CDK1 axis, indicating its potential as a diagnostic and therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Circular RNAs (circRNAs) are endogenous non-coding RNAs involved in biological processes.
  • Non-coding RNAs, particularly circRNAs, are increasingly implicated in cancer progression.
  • The specific roles of circRNAs in hepatocellular carcinoma (HCC) require further elucidation.

Purpose of the Study:

  • To investigate the expression patterns and functions of circRNAs in HCC.
  • To identify specific circRNAs involved in HCC progression and metastasis.
  • To explore the potential of circRNAs as diagnostic and therapeutic targets for HCC.

Main Methods:

  • CircRNA sequencing to identify differentially expressed circRNAs in HCC.
  • Quantitative real-time PCR, Northern blotting, and in situ hybridization to analyze circSLC7A11 expression and localization.
  • In vitro cell-based assays and in vivo mouse models to assess the impact of circSLC7A11 on HCC malignancy and metastasis.
  • Bioinformatics, RNA pulldown, RNA immunoprecipitation, and luciferase reporter assays to elucidate the molecular mechanisms of circSLC7A11.

Main Results:

  • CircSLC7A11 (hsa_circ_0070975) was significantly overexpressed in HCC tissues and cells and associated with poor prognosis.
  • In vitro and in vivo studies demonstrated that circSLC7A11 accelerates HCC progression and metastasis.
  • The mechanism involves the circSLC7A11/miR-330-3p/CDK1 axis, highlighting a novel regulatory pathway.

Conclusions:

  • CircSLC7A11 plays a critical role in promoting HCC progression and metastasis.
  • The circSLC7A11/miR-330-3p/CDK1 axis represents a key pathway in HCC development.
  • CircSLC7A11 emerges as a promising novel diagnostic and therapeutic target for HCC treatment.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.2K